BridgeMD
New treatment option for Severe Chest Trauma
Official title EffecT of eARly analGesia With Erector Spinae Plane Block to Reduce Ventilation After Severe Chest Trauma
ClinicalTrials.gov ID: NCT05920109
What this study is testing
- What it's testing
- Blunt chest trauma is commonly associated with rib fractures and early pain management is a key goal after chest trauma. In spontaneous breathing patients, pain limits coughing efficiency and secretion clearance, thereby potentially leading to progressive atelectasis, loss of functional residual capacity (FRC) and, ultimately, respiratory distress.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age \> 18 years
- Blunt chest trauma with 3 or more rib fractures on Thoracic CT scan
- With spontaneous breathing or under mechanical ventilation in the trauma bay
- Requiring an intensive (or intermediate) care unit admission
You likely can't join if
- Pre-hospital cardiac arrest
- Patient not expected to survive within the first 72 hours
- Uncontrolled haemodynamic instability despite initial resuscitation (systolic arterial blood pressure lower than 90 mmHg at the time of catheter...
- Mechanical ventilation for severe traumatic brain injury (Abbreviated Injury Score, AIS, head \> 2)
- Spinal cord injury at the cervical or thoracic levels
- Hypovolaemia.
See the full eligibility criteria
- Age \> 18 years
- Blunt chest trauma with 3 or more rib fractures on Thoracic CT scan
- With spontaneous breathing or under mechanical ventilation in the trauma bay
- Requiring an intensive (or intermediate) care unit admission
- Pre-hospital cardiac arrest
- Patient not expected to survive within the first 72 hours
- Uncontrolled haemodynamic instability despite initial resuscitation (systolic arterial blood pressure lower than 90 mmHg at the time of catheter insertion)
- Mechanical ventilation for severe traumatic brain injury (Abbreviated Injury Score, AIS, head \> 2)
- Spinal cord injury at the cervical or thoracic levels
- Hypovolaemia.
- Hypersensitivity to ropivacaine or other amide-bound local anaesthetics
- Subject in exclusion period of another treatment study
- Pregnant, breastfeeding women
The study team makes the final eligibility decision.
Where it's taking place
- Bordeaux, France
- Clamart, France
- Clermont-Ferrand, France
- Clichy, France
- Épagny, France
- Grenoble, France
- Lille, France
- Paris, France
- Pierre-Bénite, France
- Toulon, France
- Toulouse, France
- Tours, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bordeaux, France; Clamart, France; Clermont-Ferrand, France; Clichy, France; Épagny, France; Grenoble, France and 6 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.